SCHEMBL648120

SCHEMBL648120

CCCCn1c(-c2ccccc2C)nc(Cl)c1CN(CCC(C)C)Cc1ccc(OC)cc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 2/20 0.38
CRHR1 P34998 7/20 0.38
L3MBTL1 Q9Y468 2/20 0.35
TP53 P04637 2/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
GAA P10253 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3R2 O00459 1/20 0.33
PIK3CG P48736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650477 0.92 KMT2A (0.34) CRHR1TP53SMN1; SMN2KMT2AMEN1
SCHEMBL5181418 0.91 SMPD1 (0.40) SMPD1CRHR1L3MBTL1TP53MAPT
SCHEMBL649586 0.91 CALM1 (0.38) CRHR1MAPTKMT2AMEN1PIK3CD
SCHEMBL651183 0.88 CRHR1 (0.39) CRHR1L3MBTL1MAPTKMT2AMEN1
SCHEMBL649425 0.88 KMT2A (0.37) KMT2ADRD2
SCHEMBL649371 0.87 CRHR1 (0.38) CRHR1L3MBTL1MAPTKMT2AMEN1
SCHEMBL648095 0.86 LPAR1 (0.40) KMT2A
SCHEMBL5181414 0.86 CRHR1 (0.36) SMPD1CRHR1L3MBTL1TP53MAPT
SCHEMBL648465 0.85 RORC (0.36) CRHR1SMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL650387 0.85 BCHE (0.35) CRHR1L3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed